Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized trial of deferiprone vs deferasirox in transfusion-dependent beta thalassemia
2016-004829-16Phase 3Terminated
- Sponsor
- Fondazione Franco e Piera Cutino
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in beta thalassemia comparing Deferiprone with Deferasirox (2 arms). Primary endpoint: Serum ferritin change at 18 months. Started Dec 2019; status: terminated.
02
Drugs
deferipronedeferasirox
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on 2016-004829-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004829-16.